11 min listen
Episode: 50 - Pivoting Research with Antibody Drug Conjugates
Episode: 50 - Pivoting Research with Antibody Drug Conjugates
ratings:
Length:
31 minutes
Released:
Jun 13, 2023
Format:
Podcast episode
Description
In this month’s episode of The Chain, Greg M. Thurber, associate professor of chemical engineering and biomedical engineering at the University of Michigan, sits with moderator Nimish Gera, vice president of biologics at Mythic Therapeutics, to talk about the development of antibody drug conjugates (ADCs). Thurber details the history of ADCs and the skepticism facing the field during the mid-2010s, despite showing great promise in anticancer treatment. He also discusses how recent FDA approvals and breakthroughs have reignited interest and pivoted research toward designing more successful ADCs. Finally, he shares his thoughts on the exciting developments in the field in the next few years, including how ADCs could play a key role in polytherapy.
Released:
Jun 13, 2023
Format:
Podcast episode
Titles in the series (63)
Episode 04: Toward in silico Lead Discovery – the Advent of AI and Machine Learning w/ Lars Linden, PhD, Head, Protein Biochemistry, Biologics Research, Bayer by The Chain: Protein Engineering Podcast